Delivery Order SPE2DB20D3103-SPE2DB25FN3B5
Award Date
4/4/25
Potential Completion Date
4/7/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Pimecrolimus 1% Cream 30GM, a pharmaceutical product, with a ceiling value of $1,322.25 and a period of performance through March 14, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $1,022.04, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pimecrolimus 1% Cream, a topical medication, with a final completion date of August 1, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
This federal contract award, with a ceiling value of $13,693.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order and is for the procurement of Pimecrolimus 1% Cream, a specialty pharmaceutical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,209.61 firm fixed-price delivery order is for the supply of Pimecrolimus 1% Cream 30GM, with a period of performance through January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $2,175.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PIMECROLIMUS 1% CREAM 30GM, a pharmaceutical product, with a completion date of December 12, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,013.34 firm fixed-price delivery order is for the supply of Pimecrolimus 1% Cream, a topical medication. The contract has an ultimate completion date of August 31, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,010.33 firm fixed-price delivery order is for the supply of Pimecrolimus 1% Cream 60GM, a specialty medication. The contract has an ultimate completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Pimecrolimus 1% Cream in 100 gram quantities. The contract has a ceiling value of $1,077.13 and is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency, a defense agency. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency...
This federal contract award is for the delivery of Pimecrolimus 1% Cream 30GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,367.87 and was awarded on April 25, 2022, with an ultimate completion date of April 26, 2022. This is a firm fixed-price delivery order contract,...
This federal contract award, with ID SPE2DB22D1202|SPE2DB23FHPV4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,696.20 firm fixed-price delivery order is for the supply of Pimecrolimus 1% Cream 60GM, a pharmaceutical product. This award is not designated as a set-aside contract. The prime contractor, Amerisourcebergen Drug Corp, is a subsidiary of the parent company Cencora, Inc. Both entities are for-profit...